Acceptability and preferences regarding long-acting injectable antiretroviral therapy among people with HIV in Pakistan
LAI-ART is acceptable to people with HIV in Pakistan, offering adherence and privacy benefits. However, successful implementation depends on addressing concerns around safety, supply, and access through responsive, stigma-free, and people-centered care models.
Authors
- Nasim Akhtar (ORCID: https://orcid.org/0000-0002-5344-2027)
- Muhammad Zia Shahid (ORCID: https://orcid.org/0000-0002-0551-6247)
- Malik Muhammad Umair (ORCID: https://orcid.org/0000-0003-3307-3049)
- Musarat Jabeen
- Faizur Rehman
- Mehran Riaz
- Masood-Ur- Rehman
- Ali Ahmed
Institutions
- Riphah International University (PK)
- University of California System (US)
- University of California San Diego (US)
- Sarepta Therapeutics (United States) (US)
- National Agency for the Control of AIDS (NG)
- Pakistan Institute of Medical Sciences (PK)
Publication Details
- Journal
- HIV Research & Clinical Practice
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1080/25787489.2026.2635223
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00